Further, we sorted ADGRG1+/−CD8+ T cells from AML patients and cocultured them with matched blast cells for 24 h to evaluate their cell-killing ability (Fig. 6K, Supplementary Table S11). The gene discussed is ADGRG1; the disease is acute myeloid leukemia.